These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25732488)

  • 1. New analysis reexamines the value of cancer care in the United States compared to Western Europe.
    Soneji S; Yang J
    Health Aff (Millwood); 2015 Mar; 34(3):390-7. PubMed ID: 25732488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should we value lives lost to cancer?
    Ramsey SD
    J Natl Cancer Inst; 2008 Dec; 100(24):1742-3. PubMed ID: 19066279
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimating the cost of cancer care in the United States: a work very much in progress.
    Lipscomb J
    J Natl Cancer Inst; 2008 May; 100(9):607-10. PubMed ID: 18445816
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization.
    Gatta G; Trama A; Capocaccia R
    J Natl Cancer Inst Monogr; 2013; 2013(46):79-87. PubMed ID: 23962511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates and projections of value of life lost from cancer deaths in the United States.
    Yabroff KR; Bradley CJ; Mariotto AB; Brown ML; Feuer EJ
    J Natl Cancer Inst; 2008 Dec; 100(24):1755-62. PubMed ID: 19066267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
    Hall PS; Hamilton P; Hulme CT; Meads DM; Jones H; Newsham A; Marti J; Smith AF; Mason H; Velikova G; Ashley L; Wright P
    Br J Cancer; 2015 Mar; 112(5):948-56. PubMed ID: 25602964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
    Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the cost of caring for people with cancer at the end of life: A modelling study.
    Round J; Jones L; Morris S
    Palliat Med; 2015 Dec; 29(10):899-907. PubMed ID: 26199134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients.
    Landrum MB; Meara ER; Chandra A; Guadagnoli E; Keating NL
    Health Aff (Millwood); 2008; 27(1):159-68. PubMed ID: 18180491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer outcomes in low-income elders: is there an advantage to being on Medicaid?
    Koroukian SM; Bakaki PM; Owusu C; Earle CC; Cooper GS
    Medicare Medicaid Res Rev; 2012; 2(2):. PubMed ID: 24800139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer mortality surveillance--United States, 1990-2000.
    Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
    MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.
    Gondos A; Arndt V; Holleczek B; Stegmaier C; Ziegler H; Brenner H
    Int J Cancer; 2007 Jul; 121(2):395-400. PubMed ID: 17372898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
    Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
    J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we finally winning the war on cancer?
    Cutler DM
    J Econ Perspect; 2008; 22(4):3-26. PubMed ID: 19768842
    [No Abstract]   [Full Text] [Related]  

  • 20. The economic burden of cancer in the UK: a study of survivors treated with curative intent.
    Marti J; Hall PS; Hamilton P; Hulme CT; Jones H; Velikova G; Ashley L; Wright P
    Psychooncology; 2016 Jan; 25(1):77-83. PubMed ID: 26087260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.